Pfizer
3 statements across 3 episodes · 1 bullish · 1 bearish · 3 people on the record · first statement Jul 15, 2017 by Vijay Pande · said 10 times in 8 episodes since 2017 · across every show →
Mentions by year
brought up most by Safi Bahcall (3), Vijay Pande (1), Russ Altman (1), Michael Copeland (1), Lada Nuzhna (1), Koki Hirasaki (1), Jonathan Lim (1), Jeff Woo (1)
tap a year for its mentions
2025 1 mention in 1 episode
2020 1 mention in 1 episode
2019 7 mentions in 5 episodes 1 per episode
- a16z Podcast | Incenting Innovation Inside, Loonshots to Moonshots
- What’s with All the Bio M&A in 2019?: A Quick Take
- a16z Podcast | The Genetics Of Drug Delivery
- a16z Podcast | Move Fast But Don't Break Things (When It Comes to Computational Biology)
- a16z Podcast | Nootropics and the Best Version of Your Brain, Yourself
- every mention in 2019, scene by scene →
2017 1 mention in 1 episode
Everything said about Pfizer, oldest first
Jul 15, 2017 bullish
Pande: Digital health startups could be acquired by pharma or tech giants
“I could see a Pfizer buying Omada, you know, and maybe coupling with a drug or maybe not. I could see Google buying a company like Omada. I could see Freenome being bought either by a therapeutics company that wants a diagnostic, or by, let's say, a sequencing…”
Feb 28, 2019 neutral
Apr 1, 2019 negative
Bahcall: Ancient empires stifled innovation much like modern big pharma
“China, India, and the Islamic empires were a lot like the Merck, Pfizer, and Novartis of today. They were global, everywhere, dominant. They're phenomenal at franchises. So in India, you've had the Taj Mahal. You know, in China, they built the Great Wall and j…”